EUVIMEDEUVIMED entdecken
Open Access

Red light‐activated depletion of drug‐refractory glioblastoma stem cells and chemosensitization of an acquired‐resistant mesenchymal phenotype

Bryan Q Spring iD, Kohei Watanabe, Megumi Ichikawa, Srivalleesha Mallidi iD, Tatsuyuki Matsudaira, Dmitriy Timerman, Joseph W R Swain, Zhiming Mai, Hiroaki Wakimoto, Tayyaba Hasan

Photochemistry and Photobiology · 2025

DOI: 10.1111/php.13985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Photochemistry and Photobiology, 2025. Verfasst von Bryan Q Spring und 9 weiteren Autor:innen. Beteiligte Einrichtung: Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Glioblastoma, Neoplastic Stem Cells, Drug Resistance, Neoplasm, Light. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Massachusetts General Hospital, Canon Medical Systems USA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma stem cells (GSCs) are potent tumor initiators resistant to radiochemotherapy, and this subpopulation is hypothesized to re‐populate the tumor milieu due to selection following conventional therapies. Here, we show that 5‐aminolevulinic acid (ALA) treatment—a pro‐fluorophore used for fluorescence‐guided cancer surgery—leads to elevated levels of fluorophore conversion in patient‐derived GSC cultures, and subsequent red light‐activation induces apoptosis in both intrinsically temozolomide chemotherapy‐sensitive and ‐resistant GSC phenotypes. Red light irradiation of ALA‐treated cultures also exhibits the ability to target mesenchymal GSCs (Mes–GSCs) with induced temozolomide resistance. Furthermore, sub‐lethal light doses restore Mes–GSC sensitivity to temozolomide, abrogating GSC‐acquired chemoresistance. These results suggest that ALA is not only useful for fluorescence‐guided glioblastoma tumor resection, but that it also facilitates a GSC drug‐resistance agnostic, red light‐activated modality to mop up the surgical margins and prime subsequent chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaNeoplastic Stem CellsDrug Resistance, NeoplasmLightHumansTemozolomideAminolevulinic AcidPhenotypeApoptosisBrain NeoplasmsCell Line, TumorRed Light

Stichwörter der Autor:innen

cancer stem cellschemosensitizationdrug‐resistanceglioblastomamesenchymalphotodynamic therapy

Substanzen

TemozolomideAminolevulinic Acid

Autor:innen und Institutionen

  • Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Physics, Northeastern University, Boston, Massachusetts, USA.
  • Healthcare Optics Research Laboratory, Canon USA, Inc., Cambridge, Massachusetts, USA.
  • Department of Biomedical Engineering, Tufts University, Medford, Massachusetts, USA.
  • Brain Tumor Research Center and Molecular Neurosurgery Laboratory, Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Health Sciences and Technology, Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

ORCID-Profile: Bryan Q Spring, Srivalleesha Mallidi

Förderung

  • NCI NIH HHS
  • Massachusetts General Hospital
  • Canon Medical Systems USA
  • National Cancer Institute

Zitieren

APA

Spring, B. Q., Watanabe, K., Ichikawa, M., Mallidi, S., Matsudaira, T., Timerman, D., Swain, J. W. R., Mai, Z., Wakimoto, H., & Hasan, T. (2025). Red light‐activated depletion of drug‐refractory glioblastoma stem cells and chemosensitization of an acquired‐resistant mesenchymal phenotype. Photochemistry and Photobiology. https://doi.org/10.1111/php.13985

Vancouver

Spring BQ, Watanabe K, Ichikawa M, Mallidi S, Matsudaira T, Timerman D, et al. Red light‐activated depletion of drug‐refractory glioblastoma stem cells and chemosensitization of an acquired‐resistant mesenchymal phenotype. Photochemistry and Photobiology. 2025. doi:10.1111/php.13985

BibTeX
@article{Spring2025,
  author = {Spring, Bryan Q and Watanabe, Kohei and Ichikawa, Megumi and Mallidi, Srivalleesha and Matsudaira, Tatsuyuki and Timerman, Dmitriy and Swain, Joseph W R and Mai, Zhiming and Wakimoto, Hiroaki and Hasan, Tayyaba},
  title = {Red light‐activated depletion of drug‐refractory glioblastoma stem cells and chemosensitization of an acquired‐resistant mesenchymal phenotype},
  journal = {Photochemistry and Photobiology},
  year = {2025},
  doi = {10.1111/php.13985}
}
Kostenlos starten →